Home › Multiple Myeloma › Ohio › Dayton
Multiple Myeloma clinical trials in Dayton, OH
3 studies for Multiple Myeloma are looking for participants at sites in and around Dayton (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
RecruitingPhase 3
- Dayton Physicians Network Urology, Dayton
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RecruitingPhase 2
- Kettering Health, Kettering · 5 mi away
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
RecruitingPhase 3
- Dayton Physician LLC-Miami Valley Hospital North, Dayton
- Greater Dayton Cancer Center, Kettering · 5 mi away
- Kettering Medical Center, Kettering · 5 mi away
- and 4 more
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO26 studies
- Columbus, OH24 studies
- Baldwin Park, CA23 studies
- St. Louis, MO23 studies
- Rochester, MN23 studies
- Washington, DC22 studies
Other studies in Dayton
- Lung Cancer14 studies
- Non-Small Cell Lung Cancer13 studies
- Ovarian Cancer9 studies
- Cancer (all types)8 studies
- Steatotic Liver Disease8 studies
- Heart Failure8 studies
- Endometrial Cancer8 studies
- Prostate Cancer7 studies
- Breast Cancer7 studies
- Melanoma7 studies
- Obesity7 studies
- Ulcerative Colitis7 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.